ES2131313T3 - Derivados de acido nipecotico como compuestos antitromboticos. - Google Patents

Derivados de acido nipecotico como compuestos antitromboticos.

Info

Publication number
ES2131313T3
ES2131313T3 ES95914023T ES95914023T ES2131313T3 ES 2131313 T3 ES2131313 T3 ES 2131313T3 ES 95914023 T ES95914023 T ES 95914023T ES 95914023 T ES95914023 T ES 95914023T ES 2131313 T3 ES2131313 T3 ES 2131313T3
Authority
ES
Spain
Prior art keywords
acid derivatives
nipecotic acid
antithrombotic compounds
compounds
antithrombotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95914023T
Other languages
English (en)
Inventor
Mary Pat Beavers
Patricia Andrade-Gordon
William J Hoekstra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Application granted granted Critical
Publication of ES2131313T3 publication Critical patent/ES2131313T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REVELAN COMPUESTOS DERIVADOS DE ACIDO NIPECOTICO DE FORMULA (I) SON EXPUESTOS COMO UTILES EN EL TRATAMIENTO DE TRASTORNOS TROMBOTICOS TRANSMITIDOS POR LAS PLAQUETAS.
ES95914023T 1994-03-16 1995-03-14 Derivados de acido nipecotico como compuestos antitromboticos. Expired - Lifetime ES2131313T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21377294A 1994-03-16 1994-03-16
US36489694A 1994-12-27 1994-12-27

Publications (1)

Publication Number Publication Date
ES2131313T3 true ES2131313T3 (es) 1999-07-16

Family

ID=26908383

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95914023T Expired - Lifetime ES2131313T3 (es) 1994-03-16 1995-03-14 Derivados de acido nipecotico como compuestos antitromboticos.

Country Status (20)

Country Link
US (1) US5770575A (es)
EP (1) EP0746545B1 (es)
JP (1) JPH09510453A (es)
KR (1) KR100328287B1 (es)
CN (1) CN1083834C (es)
AT (1) ATE180470T1 (es)
AU (1) AU703397B2 (es)
CA (1) CA2163027A1 (es)
DE (1) DE69509875T2 (es)
DK (1) DK0746545T3 (es)
ES (1) ES2131313T3 (es)
FI (1) FI113763B (es)
GR (1) GR3030566T3 (es)
HU (1) HUT74871A (es)
MX (1) MX9504800A (es)
NO (1) NO304885B1 (es)
NZ (1) NZ283209A (es)
RU (1) RU2135470C1 (es)
TW (1) TW318179B (es)
WO (1) WO1995025091A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380215B1 (en) * 1993-09-22 2002-04-30 Fujisawa Pharmaceutical Co., Ltd Beta-alanine derivative and a process for the preparation thereof
IL117495A (en) * 1995-03-17 2002-05-23 Fujisawa Pharmaceutical Co History of b-alanine, the process for their preparation and the pharmaceutical preparations containing them
KR19990087694A (ko) * 1996-03-13 1999-12-27 후지야마 아키라 피브리노겐 수용체 길항제로서의 N-[(R)-１-{３-(４-피페리딜)프로피오닐-３-피페리딜카보닐]-２(S)-아세틸아미노-β-알라닌
ATE421952T1 (de) * 1996-05-01 2009-02-15 Ortho Mcneil Pharm Inc Carboxamidderivate von pyrrolidin, piperidin und hexahydropiperizin für behandlung von thrombosen
EP1184374B1 (en) * 1996-05-01 2009-01-28 Ortho-McNeil Pharmaceutical, Inc. Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6066651A (en) * 1997-10-29 2000-05-23 Ortho-Mcneil Pharmaceutical, Inc. Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders
US6020347A (en) * 1997-11-18 2000-02-01 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
WO1999025685A1 (en) * 1997-11-18 1999-05-27 Merck & Co., Inc. 4-substituted-4-piperidine carboxamide derivatives
SK13562001A3 (sk) * 1999-03-22 2002-08-06 Ortho-Mcneil Pharmaceutical, Inc. Spôsob prípravy [S-(R*,S*)]-beta-[[[1-[1-oxo-3-(4-piperidinyl)- propyl]-3-piperidinyl]karbonyl]amino]-3-pyridínpropánovej kyseliny a derivátov
AUPQ570100A0 (en) 2000-02-17 2000-03-09 Fujisawa Pharmaceutical Co., Ltd. Beta-alanine derivatives and their use as receptor antagonists
JP4910695B2 (ja) 2004-02-25 2012-04-04 アステラス製薬株式会社 血栓造影剤
EP3184149A1 (en) * 2015-12-23 2017-06-28 Julius-Maximilians-Universität Würzburg Soluble glycoprotein v for treating thrombotic diseases
CN109734655B (zh) * 2019-03-11 2020-06-02 都创(上海)医药科技有限公司 一种fkbp配体的同型二聚体合成工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
TW201303B (es) * 1990-07-05 1993-03-01 Hoffmann La Roche
IE912760A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
AU3141693A (en) * 1991-11-22 1993-06-15 Friedman, Mark M. Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
JP3401005B2 (ja) * 1992-12-11 2003-04-28 ユニバーシティ オブ フロリダ 有害生物の防除のための材料および方法
US5559209A (en) * 1993-02-18 1996-09-24 The General Hospital Corporation Regulator regions of G proteins

Also Published As

Publication number Publication date
NZ283209A (en) 1998-04-27
AU2119195A (en) 1995-10-03
CA2163027A1 (en) 1995-09-21
GR3030566T3 (en) 1999-10-29
FI955498A0 (fi) 1995-11-15
MX9504800A (es) 1997-05-31
RU2135470C1 (ru) 1999-08-27
EP0746545A1 (en) 1996-12-11
NO954609D0 (no) 1995-11-15
AU703397B2 (en) 1999-03-25
US5770575A (en) 1998-06-23
WO1995025091A3 (en) 1995-10-12
EP0746545B1 (en) 1999-05-26
DE69509875T2 (de) 1999-12-09
DK0746545T3 (da) 1999-11-08
FI113763B (fi) 2004-06-15
DE69509875D1 (de) 1999-07-01
WO1995025091A2 (en) 1995-09-21
ATE180470T1 (de) 1999-06-15
FI955498A (fi) 1996-01-15
NO304885B1 (no) 1999-03-01
KR100328287B1 (ko) 2002-10-11
NO954609L (no) 1996-01-05
HU9503270D0 (en) 1996-05-28
TW318179B (en) 1997-10-21
CN1128022A (zh) 1996-07-31
CN1083834C (zh) 2002-05-01
JPH09510453A (ja) 1997-10-21
HUT74871A (en) 1997-02-28

Similar Documents

Publication Publication Date Title
ES2131313T3 (es) Derivados de acido nipecotico como compuestos antitromboticos.
AU1973997A (en) Pentafluorobenzenesulfonamides and analogs
DK399588A (da) Pentasaccharider
ES2150808T3 (es) Forma cristalina de (4-trifluorometil)-anilida de acido 5-metilisoxazol-4-carboxilico.
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
DE3485419D1 (de) Glyzerinderivate.
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
ES2108004T3 (es) Nuevas alquil piperidinas sustituidas y su empleo como inhibidores de la sintesis de colesterol.
AU686104B2 (en) Substituted amidinonaphthyl ester derivatives
DE69320420D1 (de) Benzyl- und Benzhydryl Alkohole

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 746545

Country of ref document: ES